By PrincessSafiya Byers This story was originally published by Milwaukee Neighborhood News Service, where you can find other stories reporting on fifteen city neighborhoods in Milwaukee. Visit milwaukeenns.org. The history of medical research is rife with instances of specific groups of people underrepresented in clinical trials, people who have then had adverse effects to novel medications and […]
Ask Dr. Kevin: Understanding Clinical Trials and Sickle Cell Disease in the Black Community
By Dr. Kevin Williams (Chief Medical Officer, Pfizer Rare Disease Unit) This article is the third installment in the “Ask Dr. Kevin” series, brought to you by Pfizer Rare Disease in collaboration with the National Newspaper Publishers Association (NNPA) to increase understanding of sickle cell disease. Clinical trials are critical to bringing new medicines to […]
Pfizer Officials Call For Blacks to Participate in Sickle Cell Disease Clinical Trials
By Joan H. Allen NNPA News Wire Contributor June 19, 2016 marks World Sickle Cell Day. In a desire to help create a greater awareness of sickle cell disease (SCD) and increase their efforts to find a cure, Pfizer invited members of the Black Press to meet and discuss with key members of their rare […]